Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Large Volume Increase – Still a Buy?

Posted by on Jun 30th, 2026

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) shares saw unusually-strong trading volume on Tuesday . Approximately 82,115 shares changed hands during trading, a decline of 39% from the previous session’s volume of 135,097 shares.The stock last traded at $8.51 and had previously closed at $8.65.

Analysts Set New Price Targets

A number of analysts have commented on SGIOY shares. The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research report on Monday, June 15th. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a report on Monday, May 25th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Shionogi & Co., Ltd. Unsponsored ADR currently has a consensus rating of “Buy”.

Read Our Latest Stock Report on SGIOY

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

The company has a debt-to-equity ratio of 0.01, a current ratio of 1.58 and a quick ratio of 1.46. The firm has a market cap of $14.53 billion, a price-to-earnings ratio of 10.68, a price-to-earnings-growth ratio of 3.31 and a beta of 0.08. The company has a fifty day moving average price of $9.27 and a two-hundred day moving average price of $9.90.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) last released its earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.56% and a net margin of 41.08%.The firm had revenue of $881.71 million for the quarter, compared to analyst estimates of $895.52 million. As a group, equities research analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.8 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

(Get Free Report)

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.

Featured Stories

Receive News & Ratings for Shionogi & Co. Ltd. Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.